| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| John G Csernansky, Ramy Mahmoud, Ronald Brenne. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England journal of medicine. vol 346. issue 1. 2002-01-21. PMID:11777998. |
a comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. |
2002-01-21 |
2023-08-12 |
Not clear |
| John G Csernansky, Ramy Mahmoud, Ronald Brenne. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England journal of medicine. vol 346. issue 1. 2002-01-21. PMID:11777998. |
we performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an older, conventional neuroleptic drug, haloperidol, in terms of the rate of relapse in patients with schizophrenia and schizoaffective disorder. |
2002-01-21 |
2023-08-12 |
Not clear |
| J P Lindenmayer, J Volavka, J Lieberman, B Sheitman, L Citrome, M Chakos, P Czobor, B Parker, A Iskande. Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial. Journal of clinical psychopharmacology. vol 21. issue 4. 2002-01-09. PMID:11476131. |
this article presents an open-label, prospective, 14-week trial with olanzapine in patients with schizophrenia and schizoaffective disorder selected for unambiguous resistance to either clozapine or risperidone and to typical antipsychotics. |
2002-01-09 |
2023-08-12 |
Not clear |
| S Kasper, D Rosillon, I Duchesn. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study. International clinical psychopharmacology. vol 16. issue 4. 2002-01-02. PMID:11459331. |
risperidone olanzapine drug outcomes studies in schizophrenia (rodos): efficacy and tolerability results of an international naturalistic study. |
2002-01-02 |
2023-08-12 |
Not clear |
| S Kasper, D Rosillon, I Duchesn. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study. International clinical psychopharmacology. vol 16. issue 4. 2002-01-02. PMID:11459331. |
the risperidone olanzapine drug outcomes studies in schizophrenia (rodos) programme was an international series of naturalistic studies designed to evaluate drug use patterns and outcomes. |
2002-01-02 |
2023-08-12 |
Not clear |
| S Kasper, D Rosillon, I Duchesn. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study. International clinical psychopharmacology. vol 16. issue 4. 2002-01-02. PMID:11459331. |
in conclusion, the clinical outcomes reported by rodos suggest that risperidone may be more effective as a first-line therapy drug for schizophrenia than olanzapine. |
2002-01-02 |
2023-08-12 |
Not clear |
| S Kasper, M Jones, I Duchesn. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study. International clinical psychopharmacology. vol 16. issue 4. 2002-01-02. PMID:11459332. |
risperidone olanzapine drug outcomes studies in schizophrenia (rodos): health economic results of an international naturalistic study. |
2002-01-02 |
2023-08-12 |
Not clear |
| S Kasper, M Jones, I Duchesn. Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): health economic results of an international naturalistic study. International clinical psychopharmacology. vol 16. issue 4. 2002-01-02. PMID:11459332. |
we report the health economic data from the risperidone olanzapine drug outcomes studies in schizophrenia (rodos) programme. |
2002-01-02 |
2023-08-12 |
Not clear |
| L Citrome, J Volavka, P Czobor, B Sheitman, J P Lindenmayer, J McEvoy, T B Cooper, M Chakos, J A Lieberma. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. Psychiatric services (Washington, D.C.). vol 52. issue 11. 2001-12-14. PMID:11684748. |
effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. |
2001-12-14 |
2023-08-12 |
Not clear |
| J Lavalaye, J Booij, D H Linszen, L Reneman, E A van Roye. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. vol 156. issue 1. 2001-12-05. PMID:11465633. |
higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. |
2001-12-05 |
2023-08-12 |
Not clear |
| A Valevski, T Loebl, T Keren, L Bodinger, A Weizma. Response of catatonia to risperidone: two case reports. Clinical neuropharmacology. vol 24. issue 4. 2001-12-04. PMID:11479394. |
the present study describes two patients, both of yemenite origin, with catatonic schizophrenia who responded to treatment with risperidone. |
2001-12-04 |
2023-08-12 |
Not clear |
| A Aleman, R S Kah. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 11. issue 4. 2001-12-04. PMID:11532383. |
effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. |
2001-12-04 |
2023-08-12 |
Not clear |
| A Aleman, R S Kah. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 11. issue 4. 2001-12-04. PMID:11532383. |
in the present quantitative review the published evidence regarding the effects of risperidone on hostility and aggression in schizophrenia is evaluated. |
2001-12-04 |
2023-08-12 |
Not clear |
| A Aleman, R S Kah. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 11. issue 4. 2001-12-04. PMID:11532383. |
we conclude that risperidone is superior to classical antipsychotics and placebo in the treatment of hostility and aggression in schizophrenia. |
2001-12-04 |
2023-08-12 |
Not clear |
| A Labelle, M Light, F Dunba. Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 46. issue 6. 2001-10-04. PMID:11526810. |
risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response. |
2001-10-04 |
2023-08-12 |
Not clear |
| A Labelle, M Light, F Dunba. Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 46. issue 6. 2001-10-04. PMID:11526810. |
given the renewed interest in the role of sex differences in schizophrenia, we undertook a post hoc analysis to determine whether sex differences in treatment response were present among outpatients with schizophrenia who received risperidone in an 8-week, open-label, phase iv clinical study. |
2001-10-04 |
2023-08-12 |
Not clear |
| Y Sekine, N Takei, M Iyo, N Mori, M Minami, T Oht. Effective risperidone treatment for simple deteriorative disorder (simple schizophrenia): a case report. Schizophrenia research. vol 50. issue 3. 2001-09-27. PMID:11439242. |
effective risperidone treatment for simple deteriorative disorder (simple schizophrenia): a case report. |
2001-09-27 |
2023-08-12 |
Not clear |
| D C Henderson, D C Goff, C E Connolly, C P Borba, D Hayde. Risperidone added to clozapine: impact on serum prolactin levels. The Journal of clinical psychiatry. vol 62. issue 8. 2001-09-27. PMID:11561931. |
several years ago, we reported that the addition of risperidone to clozapine improved response in some patients with schizophrenia. |
2001-09-27 |
2023-08-12 |
Not clear |
| D C Henderson, D C Goff, C E Connolly, C P Borba, D Hayde. Risperidone added to clozapine: impact on serum prolactin levels. The Journal of clinical psychiatry. vol 62. issue 8. 2001-09-27. PMID:11561931. |
the goal of this study was to determine whether the addition of risperidone to clozapine results in an elevation of serum prolactin levels in patients with chronic schizophrenia or schizoaffective disorder. |
2001-09-27 |
2023-08-12 |
Not clear |
| E Vieta, M Herraiz, A Fernández, C Gastó, A Benabarre, F Colom, A Martínez-Arán, M Reinare. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). The Journal of clinical psychiatry. vol 62. issue 8. 2001-09-27. PMID:11561935. |
analyses of data from clinical trials of risperidone in schizophrenia and small open-label studies in mania suggest that risperidone may have this broad efficacy profile. |
2001-09-27 |
2023-08-12 |
Not clear |